TORTORA, GENOVEFFA
 Distribuzione geografica
Continente #
EU - Europa 62
NA - Nord America 46
AS - Asia 20
Totale 128
Nazione #
US - Stati Uniti d'America 46
PL - Polonia 26
IT - Italia 16
IE - Irlanda 8
CN - Cina 6
HK - Hong Kong 6
SE - Svezia 6
JO - Giordania 4
RU - Federazione Russa 4
VN - Vietnam 2
CH - Svizzera 1
FI - Finlandia 1
SG - Singapore 1
TH - Thailandia 1
Totale 128
Città #
Warsaw 26
Dublin 8
Chandler 7
Fairfield 5
Hong Kong 4
Modena 4
Moscow 4
New York 4
Seattle 3
Altamura 2
Ann Arbor 2
Ashburn 2
Bologna 2
Cambridge 2
Dong Ket 2
Lawrence 2
Lurate Caccivio 2
Redwood City 2
Shanghai 2
Vicopisano 2
Bangkok 1
Beijing 1
Bern 1
Boston 1
Buffalo 1
Castel San Giovanni 1
Florence 1
Helsinki 1
Houston 1
Kent 1
Princeton 1
San Marco dei Cavoti 1
Singapore 1
Totale 100
Nome #
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 92
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 39
Totale 131
Categoria #
all - tutte 786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 3 0
2020/202140 4 4 2 4 2 5 4 4 2 6 0 3
2021/20227 0 0 0 1 0 0 0 1 0 1 2 2
2022/202346 1 8 1 1 1 6 8 3 9 0 6 2
2023/202432 0 3 4 3 4 4 0 8 1 2 3 0
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 131